Targeted Microbial Shifts and Metabolite Profiles Were Associated with Clinical Response to an Anti-Inflammatory Diet in Osteoarthritis
Nutrients · 2025
DOI: 10.3390/nu17172729 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Nutrients, 2025. Verfasst von Marta Sala-Climent und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, University of California San Diego, San Diego, CA 92093, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Metabolome, Osteoarthritis, Knee, Diet. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
Introduction
Osteoarthritis (OA) is a chronic degenerative joint disease with limited treatment options focused primarily on symptom management. Emerging evidence suggests that dietary interventions may influence inflammation and pain through modulation of the gut microbiome and metabolome.
Methods
We conducted a 4-week open-label pilot trial evaluating the effects of an anti-inflammatory dietary intervention (ITIS diet) in 20 patients with knee OA (ClinicalTrials.gov ID: NCT05559463, registered prior to enrollment; sponsor: University of California, San Diego; responsible party: Monica Guma; study start date: 1 October 2021). The following were assessed before and after the intervention: (1) clinical outcomes; (2) gut and salivary microbiomes; and (3) salivary, stool, and plasma metabolomes. Responders were defined as patients achieving ≥30% reduction in Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain scores.
Results
The ITIS diet was well-tolerated, with good adherence (66.2%) and a significant improvement in clinical outcomes, including reduced pain and improved overall health measured with the visual analog scale (VAS). Responders (n = 8) showed distinct gut microbiome and metabolome profiles compared to non-responders (n = 12). Notably, taxa within the Lachnospiraceae family exhibited dynamic, bidirectional shifts post-intervention: Anaerostipes and Limivivens were enriched among responders and negatively correlated with pain scores, while Oliverpabstia and Fusicatenibacter were depleted following dietary intervention. These taxa also showed strong correlations with anti-inflammatory metabolites, including hydroxydecanoic acid derivatives and pyridoxine. Furthermore, subsequent network analysis revealed more structured and selective microbiome–metabolome interactions in responders, specifically post-intervention.
Conclusions
This pilot study shows that a short-term anti-inflammatory dietary intervention was associated with meaningful changes in the gut microbiome and metabolome. Members of the Lachnospiraceae family emerged as key taxa associated with pain reduction and anti-inflammatory metabolite production. Our findings suggest that specific microbial responses—rather than global diversity changes—may underlie dietary responsiveness in OA. Although exploratory and limited by sample size, our results support further investigation into personalized, microbiome-informed nutritional strategies for OA management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, School of Medicine, University of California San Diego, San Diego, CA 92093, USA.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA 92093, USA.
- Department of Pediatrics, School of Medicine, University of California San Diego, San Diego, CA 92093, USA.
- VA San Diego Healthcare System, San Diego, CA 92161, USA.
- Department of Psychiatry, School of Medicine, University of California San Diego, San Diego, CA 92093, USA.
ORCID-Profile: Marta Sala-Climent, Kevin Bu, Roxana Coras, Simone Zuffa, Jessica Murillo-Saich, Helena Mannochio-Russo, Michal K Hose, Rebecca B Blank, Tiffany Holt
Förderung
- NIAMS NIH HHS
- NIA NIH HHS
- NIH HHS
- NCATS NIH HHS
- Krupp Endowed Fund
- UCSD Rheumatic Diseases Research Training Grant from the NIH/NIAMS
- NIH
Zitieren
APA
Sala-Climent, M., Bu, K., Coras, R., Cedeno, M., Zuffa, S., Murillo-Saich, J., Mannochio-Russo, H., Allaband, C., Hose, M. K., Quan, A., Choi, S. I., Nguyen, K., Golshan, S., Blank, R. B., Holt, T., Lane, N. E., Knight, R., Scher, J., Dorrestein, P., …, & Guma, M. (2025). Targeted Microbial Shifts and Metabolite Profiles Were Associated with Clinical Response to an Anti-Inflammatory Diet in Osteoarthritis. Nutrients. https://doi.org/10.3390/nu17172729
Vancouver
Sala-Climent M, Bu K, Coras R, Cedeno M, Zuffa S, Murillo-Saich J, et al. Targeted Microbial Shifts and Metabolite Profiles Were Associated with Clinical Response to an Anti-Inflammatory Diet in Osteoarthritis. Nutrients. 2025. doi:10.3390/nu17172729
BibTeX
@article{SalaCliment2025,
author = {Sala-Climent, Marta and Bu, Kevin and Coras, Roxana and Cedeno, Martha and Zuffa, Simone and Murillo-Saich, Jessica and Mannochio-Russo, Helena and Allaband, Celeste and Hose, Michal K and Quan, Anna and Choi, Soo-In and Nguyen, Katherine and Golshan, Shahrokh and Blank, Rebecca B and Holt, Tiffany and Lane, Nancy E and Knight, Rob and Scher, Jose and Dorrestein, Pieter and Clemente, Jose and Guma, Monica},
title = {Targeted Microbial Shifts and Metabolite Profiles Were Associated with Clinical Response to an Anti-Inflammatory Diet in Osteoarthritis},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17172729}
}
EUVIMED